| G1 | G2 | Inter-group | ||||
---|---|---|---|---|---|---|---|
Baseline | After 3 months | Baseline | After 3 months | cP | dP | ||
1. HR | 102 ± 7 | 71 ± 5 | 103 ± 9 | 70 ± 6 |  |  | |
 Intragroup t test | aP < 0.001* | bP < 0.001* | 0.68 | 0.55 | |||
2. BP | 137 ± 7 | 130 ± 8 | 135 ± 6 | 130 ± 9 |  |  | |
85 ± 9 | 80 ± 10 | 32 ± 5 | 80 ± 6 | ||||
 Intragroup t test | aP < 0.001*, < 0.001* | bP < 0.001*, < 0.02* | 0.21 | 0.68 | |||
3. NYHA | Class I | 20 (80%) | 19 (76 %) | 12 (66.7%) | 14 (77.8%) | Â | Â |
Class II | 6 (24%) | 6 (24%) | 6 (33.3%) | 4 (22.2%) | |||
 Intragroup t test | aP = 0.03* | bP = 0.046* | 0.85 | 0.99 | |||
4. EF% | 39 ± 4.2 | 42 ± 3.0 | 38.9 ± 3.2 | 41.8 ± 3.3 |  |  | |
 Intragroup t test | aP < 0.001* | bP < 0.001* | 0.93 | 0.84 | |||
5. B blocker compliance | 24 (96%) | 24 (96%) | 17 (94%) | 17 (94%) | Â | Â | |
 Intragroup t test | aP > 0.99 | bP > 0.99 | 0.99 | 0.99 | |||
6. HbA1c | 5.8 ± 0.8 | 5.9 ± 0.3 | 5.9 ± 0.6 | 5.3 ± 0.2 |  |  | |
 Intragroup t test | aP = 0.76 | bP < 0.001* | 0.55 | < 0.001* | |||
7. Fasting glucose (mg/dl) | 102 ± 14 | 103 ± 9 | 103 ± 9 | 97 ± 7 |  |  | |
 Intragroup t test | aP = 0.73 | bP < 0.001* | 0.31 | 0.023* | |||
8. Plasma insulin (lU/ml) | 5.3 ± 3.2 | 5.4 ± 3.9 | 5.4 ± 4.1 | 3.5 ± 0.23 |  |  | |
 Intragroup t test | aP = 0.62 | bP = 0.01* | 0.92 | 0.046* | |||
9. HOMA-IR | 1.31 ± 0.29 | 1.37 ± 0.3 | 1.37 ± 0.3 | 1.21 ± 0.08 |  |  | |
 Intragroup t test | aP = 0.41 | bP = 0.01* | 0.52 | 0.01* | |||
10. Plasma norepinephrine (pg/ml%) | 530 ± 159 | 436 ± 30 | 531 ± 171 | 499 ± 102 |  |  | |
 Intragroup t test | aP = 0.002* | bP = 0.08 | 0.98 | 0.019* | |||
11. Plasminogen activator I (ng/ml) | 9.9 ± 3.2 | 9.8 ± 2.7 | 10.2 ± 2.5 | 10.1 ± 3.3 |  |  | |
 Intragroup t test | aP = 0.37 | bP = 0.81 | 0.74 | 0.75 |